Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2024-06-11 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled investor and analyst meeting/conference. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events and information. The document mentions that the discussion will be based on previously submitted earnings presentation and publicly available financial information. The document is short (1756 characters) and serves as an announcement of an upcoming event rather than containing any financial data or detailed report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit into other specific categories like Earnings Release or Investor Presentation itself.
2024-06-11 English
Acquisition
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) notifying the incorporation of a wholly owned subsidiary, Rossari Global DMCC, by Rossari Biotech Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a corporate event (subsidiary incorporation) rather than a financial report, management change, or other specific filings. The document length is short (2027 characters) and it is clearly an announcement under regulatory disclosure requirements. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for general regulatory announcements that do not fit other specific categories.
2024-05-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about scheduled investor and analyst meetings/conferences. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document states that the discussions will be based on previously disclosed financial information (Earnings Presentation) and explicitly mentions no unpublished price sensitive information will be shared. The document is short (2683 characters) and serves as an announcement of upcoming investor events rather than containing any financial data or detailed report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit into other specific categories like Earnings Release or Investor Presentation.
2024-05-22 English
Demise
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the demise of a member of the promoter group of the company. It references SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 30 and 31A, which pertain to disclosure of material events and changes in shareholding or promoter status. The content is an announcement of a change in the promoter group due to the death of an individual, not a financial report, audit, or management discussion. It is not a report or presentation but a regulatory compliance announcement about a change in company promoter group membership. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on April 30, 2024, discussing the Q4 and full fiscal year 2024 financial results of Rossari Biotech Limited. It includes opening remarks from management, financial performance data, segment-wise revenue and profit analysis, and a Q&A session with analysts. The presence of detailed financial figures, management commentary on business segments, and forward-looking statements are characteristic of a Call Transcript. The document is not merely an announcement or a brief summary but a full transcript of the earnings call, which matches the definition of a Call Transcript (CT).
2024-05-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the availability of the audio recording of the earnings conference call for Q4 FY24. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) and provides a link to the recording on the company's website. The document does not contain any financial data or detailed transcript but is an announcement about the earnings call recording. Given the short length (1282 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as it is a compliance announcement rather than the actual earnings release or call transcript.
2024-04-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.